ArticleBMC cancer2017

Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors.

Charles-André Philip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.